Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Traitements et mutations du cancer du poumon

Traitements et mutations du cancer du poumon

This cluster of papers focuses on the advancements in lung cancer research, particularly in understanding EGFR and ALK mutations, targeted therapy, resistance mechanisms to tyrosine kinase inhibitors, clinical trials evaluating different treatment regimens, genomic profiling for personalized medicine, and the development of treatment guidelines based on molecular biomarkers. The research also explores the concept of oncogene addiction and its implications for targeted therapies.

Questions & réponses

Aucune question publiée pour cette rubrique. Posez la première ci-dessous.